Yamato Motooka

Yamato Motooka

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2016 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
YMYamato Motooka
Yamato Motooka
KYKentaro Yoshimoto
Kentaro Yoshimoto
TSTakashi Semba
Takashi Semba
KIKoei Ikeda
Koei Ikeda
TMTakeshi Mori
Takeshi Mori
MSMakoto Suzuki
Makoto Suzuki
Hepatoid adenocarcinoma (HAC) is a rare neoplasm with aberrant hepatocellular differentiation. HAC occurs in extrahepatic organs such as the gastrointestinal tract, testes, ovaries, and lungs and frequently produces alpha-fetoprotein. A 69-year-old patient was diagnosed clinically with T2aN0M0, stage IB, non-small cell lung carcinoma. Because the tumor showed tight adhesion to the chest wall, we performed left upper lobectomy, combined resection of the 3rd and 4th ribs, and lymph node dissection. Pathological examination confirmed the diagnosis of HAC of the lung (pathological T2aN0M0, stage IB), and four courses of cisplatin and gemcitabine were administered as adjuvant chemotherapy. Genetic analysis of the epidermal growth factor receptor showed wild type. Preoperative serum alpha-fetoprotein level, a useful marker of disease progression, was elevated to 4497 ng/ml, decreasing within the normal range by about 3 months postoperatively. The patient remains alive without recurrence as of 51 months after surgery.

1 May 2019 in Lung Cancer
Verified
Journal Article
Closed access
TYTatsuya Yamada
Tatsuya Yamada
KOKunimasa Ohta
Kunimasa Ohta
YMYamato Motooka
Yamato Motooka
KFKosuke Fujino
Kosuke Fujino
SKShinji Kudoh
Shinji Kudoh
TITakaaki Ito
Takaaki Ito

1 January 2020 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
YMYamato Motooka
Yamato Motooka
KFKosuke Fujino
Kosuke Fujino
AGAlexander Gregor
Alexander Gregor
NBNicholas Bernards
Nicholas Bernards
HCHarley Chan
Harley Chan
KYKazuhiro Yasufuku
Kazuhiro Yasufuku

3 February 2021 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
HHHirokazu Hamasaki
Hirokazu Hamasaki
CSChika Shirakami
Chika Shirakami
TYTatsuya Yamada
Tatsuya Yamada
YMYamato Motooka
Yamato Motooka
KFKosuke Fujino
Kosuke Fujino
MSMakoto Suzuki
Makoto Suzuki
Background Right sleeve lower lobectomy is rarely performed because pulmonary function of the middle lobe is not spared to the extent of the other lobes and achieving a proper bronchial anastomosis is technically more difficult than other sleeve lobectomies. Case presentation We performed four right sleeve lower lobectomies and had good clinical outcomes using specific technical options, such as telescope anastomosing, pericardiotomy, interlobar dissection between the upper and middle lobes, and angioplasty of the lower pulmonary artery, if needed. Conclusions The cases presented herein demonstrated that a right sleeve lower lobectomy is one option by which to preserve the middle lobe using specific techniques and is thus recommended in select patients.

29 October 2021 in ACTA HISTOCHEMICA ET CYTOCHEMICA
Verified
Journal Article
Open access
PDF file
NKNoritaka Kudo
Noritaka Kudo
SKShinji Kudoh
Shinji Kudoh
AMAkira Matsuo
Akira Matsuo
YMYamato Motooka
Yamato Motooka
TITakaaki Ito
Takaaki Ito
Zinc finger, myeloproliferative, and mental retardation-type containing 3 (ZMYM3) is a highly conserved protein among vertebrates. Although it promotes DNA repair and moderate histone acetylation, the other functions of ZMYM3 remain unclear. We herein examined the physiological functions of ZMYM3 in human lung cancer using a ZMYM3-knockdown small cell lung cancer (SCLC) cell line. ZMYM3-knockdown SCLC cells grew slowly and the Ki-67 labeling index was lower in ZMYM3-knockdown cells than in mock cells. The subcutaneous tumors that formed after xenotransplantation into immunodeficient mice were slightly smaller in the ZMYM3-knockdown group than in the mock group. Furthermore, public RNA-sequencing data analyses showed similar RNA profiles between ZMYM3 and some cell proliferation markers. These results indicate that ZMYM3 promotes cell proliferation in human lung carcinomas, particularly SCLC.

1 September 2016
Verified
Journal Article
Closed access
TYTatsuya Yamada
Tatsuya Yamada
TMTakeshi Mori
Takeshi Mori
WNWataru Nishi
Wataru Nishi
YMYamato Motooka
Yamato Motooka
KIKoei Ikeda
Koei Ikeda
MSMakoto Suzuki
Makoto Suzuki